Hospices Brace for COVID-19 Vaccine Costs

Posted on Monday, December 21, 2020 

The U.S. Food and Drug Administration issued an emergency use authorization for the COVID-19 vaccine last week.  Health care workers and long-term care patients are in the highest priority groups.

“Being at the front of the line for vaccinations is essential to limiting spread of COVID-19 while protecting the frontline health care workforce as well as the patients and families that hospices serve in their community,” said Hannah Yang Moore, chief advocacy officer at the National Hospice & Palliative Care Organization (NHPCO). “The overarching financial concern among hospices is the labor costs associated with staff time dedicated to getting vaccinated. Where these vaccines will be accessed will greatly impact the costs to the hospices.”

Click here for the full article.

About Corridor

For over 30 years, Corridor has partnered with home-based care providers, delivering powerful solutions to support the unique challenges of caring for patients in the home. Our team of operating executives, clinicians, and nationally renowned industry experts have run provider organizations and resolved the same challenges you face.

Focusing on key operational, regulatory and financial challenges, Corridor delivers solutions and deep expertise in codingclinical documentationcompliancebilling and education.

To receive the most important industry updates, insights and news impacting home health and hospice, please make sure to sign up for our weekly newsletter.

For additional information, please contact Corridor at 1-866-263-3795.

Explore Corridor’s Solutions

Share This Story, Choose Your Platform!